Bibliografía del artículo
1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998.
2. King H, Rewers M. Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group. Bull World Health Organ 69:643-648, 1991.
3. American Diabetes Association: Nutrition principles and recommendations in diabetes. Diabetes Care 27(Suppl.1):S36-S46, 2004.
4. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997.
5. Watanabe M, Yamaoka K, Yokotsuka M, Tango T. Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers. Diabetes Care 26:3209-3214, 2003.
6. Yamaoka K, Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 28:2780-2786, 2005.
7. Vuori I. Health benefits of physical activity with special reference to interaction with diet. Diabetes 44:1010-1020, 1995.
8. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of diabetes mellitus. Report of a WHO Consultation Geneva, World Health Organization 1-59, 1999.
9. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997.
10. Kuzuya T, Nakagawa S, Satoh J, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55:65-85, 2002.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188, 1954.
12. Gilks WR, Richardson S, Speigelhalter DJ (Eds): Markov Chain Monte Carlo in practice, Chapman & Hall/CRC, London, 1998.
13. Spector P. An introduction to S and S-Plus. Duxbury Press, Belmont, CA, 1994.
14. Spiegelhalter D, Thomas A, Best N. WinBUGS Version 1.2 User manual. Cambridge: MRC Biostatistics Unit, 1999.
15. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: summary of the evidence. Ann Intern Med 137:344-346, 2002.
16. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Statist Med 21:1601-1623, 2002.
17. Moher D, Cook D.J., Eastwood S, Olkin I, Rennie D, Stoup DF, and QUOROM Group. Improving the quality of reports of meta-analyses of randomized controlled traials: the QUOROM statement. Lancet 354:1896-1900, 1999.
18. Wein P, Beischer N, Harris C, Permezel M. A trial of simple versus intensified dietary modification for prevention of progression to diabetes mellitus in women with impaired glucose tolerance. Aust N Z J Obstet Gynaecol 39:162-166, 1999.
19. Lindahl B, Nilsson TK, Jansson JH, Asplund K, Hallmans G. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 246:105-112, 1999.
20. Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KG. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Research and Clinical Practice 72:117-127, 2006.
21. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001.
22. Swinburn BA, Metcalf PA, Ley SJ. Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 24:619-624, 2001.
23. Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE. Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord 27:377-384, 2003.
24. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002.
25. Kosaka K, Noda M, Kuzuya T. Prevention of type2 diabetes by lifisty1e intervention:- a Japanese trial in IGT males. Diab Res Clin Pract 67:152-162, 2005.
26. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Djabetes Prevention Programmes hows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance. Diabetologia 49:289-297, 2006.
27. Oldroyd JC, Unwin NC, White M, Imrie K, Mathers JC, Alberti KG. Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months. Diabetes Res Clin Pract 52:29-43, 2001.
28. Diabetes Prevention Program Research Group: The Diabete prevention program: Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 22:623-634, 1999.
29. Norris SL, Schmid CH, Lau J, Engelgau MM, Smith SJ. Self-management education for adults with type 2 diabetes: A meta-analysis of the effect on glycemic control. Diabetes Care 25:1159-1171, 2002.
30. Brand-Miller J, Petocz P, Hayne S, Colagiuri S. Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 26:2261-2267, 2003.
31. Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 76:148-155, 2002.
32. Contopoulos-Ioannidis DG, Gilbody SM, Trikalinos TA, Churchill R, Wahlbeck K, Ioannidis JP. Comparison of large versus smaller randomized trials for mental health-related interventions. Am J Psychiatry 162:578-584, 2005.